← Back to Search

Singing Therapy for Cardiovascular Health

N/A

Recruiting

Research Sponsored by Medical College of Wisconsin

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up after 30-minute singing (and sham) interventions

Awards & highlights

Study Summary

This trial is testing whether singing can help improve cardiovascular biomarkers in older patients with CVD.

Who is the study for?

This trial is for older adults with a history of coronary artery disease who speak English. It's not suitable for those with pacemakers, ICDs, certain heart rhythm problems, Parkinson's disease or tremors, amputated upper extremity or arm fistula, thickened fingernails due to fungus, pregnant women, drug or heavy alcohol users, unstable coronary heart disease patients, stroke/TIA survivors within five years of cancer treatment requiring systemic therapy.Check my eligibility

What is being tested?

The study investigates if singing can improve cardiovascular health in older adults with heart disease. Participants will either sing with a music therapist or follow a guided video; there's also a control group that won't sing. The focus is on how singing affects biomarkers like endothelial function and heart rate variability after 30 minutes.See study design

What are the potential side effects?

Since the intervention involves non-strenuous activity such as singing under guidance without medical treatments involved, significant side effects are not anticipated beyond the normal risks associated with light physical activity.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ after 30-minute singing (and sham) interventions

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~after 30-minute singing (and sham) interventions

This trial's timeline: 3 weeks for screening, Varies for treatment, and after 30-minute singing (and sham) interventions for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

change in vascular (endothelial) function

Secondary outcome measures

cardiac hemodynamics

level of exertion achieved during singing

Other outcome measures

Visual Mood Score

the change in TNF-alpha, IL-1 Beta, IL-6, and IL-8

Trial Design

3Treatment groups

Active Control

Placebo Group

Group I: Singing intervention 2Active Control1 Intervention

In-person music therapy session. The music therapist will continue to coach throughout the 30-minute session. Flow Mediated dilation (FMD) and EndoPAT will be measured before and after singing.

Group II: Singing intervention 1Active Control1 Intervention

Instructional sing-a-long video. A video series will be created and recorded for the purposes of the study. Flow Mediated dilation (FMD) and EndoPAT will be measured before and after singing.

Group III: Control/sham interventionPlacebo Group1 Intervention

Subjects will have a 30-minute period of rest sitting upright (as they would be positioned for the singing interventions). This arm is meant to isolate the specific effects of the treatment rather than the potential "incidental" effects related to the research setting and measurements. During this time, subjects will undergo hearing testing. Flow Mediated dilation (FMD) and EndoPAT will be measured before and after the 30 minute rest.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor

609 Previous Clinical Trials

1,162,518 Total Patients Enrolled

Media Library

Singing Clinical Trial Eligibility Overview. Trial Name: NCT04121741 — N/A

Cardiovascular Disease Research Study Groups: Singing intervention 2, Control/sham intervention, Singing intervention 1

Cardiovascular Disease Clinical Trial 2023: Singing Highlights & Side Effects. Trial Name: NCT04121741 — N/A

Singing 2023 Treatment Timeline for Medical Study. Trial Name: NCT04121741 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to become a participant in this medical study?

"All potential participants must be diagnosed with cardiovascular diseases and between the ages of 55 to 79. 65 patients are needed for this clinical trial."

Answered by AI

What is the capacity of participants for this research endeavor?

"Affirmative. Per the clinicaltrials.gov registry, this research endeavour is still recruiting participants since its launch on January 17th 2020 and recent update of September 24th 2021. 65 individuals need to be enrolled from a single location."

Answered by AI

Is this research endeavor actively seeking participants?

"Affirmative. According to clinicaltrials.gov, the trial in question is actively seeking participants and was initially posted on January 17th 2020 with a most recent update registered on September 24th 2021. One centre has been identified for recruitment which requires 65 patients to be accepted into the study."

Answered by AI